BTC

BTC is a human G-quadruplexes regulator, inducing dynamic transitions between the ensembles of unfolded conformations to the folded state in G-quadruplexes, altering the rod shaped DNA sequences into globular quadruplexes with a decrease in hydrodynamic r

TBTC is a selective agonist of retinoid X receptor α that acts by improving behavioral deficit in Alzheimer's disease model mice.

BTCP 与豚鼠脑膜一起预孵育可增加 [3H]TCP 从 PCP 位点的解离速率。

Br-PBTC is a highly potent, 2/4 subtype-selective positive allosteric modulator of nicotinic acetylcholine receptors (nAChRs). It specifically targets α2β2, α2β4, α4β2, α4β4, (α4β2)2α4, and (α4β2)2β2 subtypes of nAChRs, with EC50 values ranging from 0.1 to 0.6 μM. Br-PBTC exerts its activity by binding to the c-tail region of an α subunit.

DU-14 (PTP1B TC-PTPPROTAC) 是一种高效且具选择性的PTP1B和TC-PTP双重PROTAC降解剂，对PTP1B和TC-PTP磷酸酶活性的 IC50分别为24.2 nM和30.1 nM。此化合物能够增强IFN-γ信号传导、促进T细胞活化，并具有抗肿瘤活性。

PTP1B TC-PTP IN-1 是一种同时抑制PTP1B和TC-PTP的抑制剂。PTP1B TC-PTP IN-1 可用于合成PROTAC靶蛋白配体DU-14 (PTP1B TC-PTP PROTAC)。

Mosunetuzumab (BTCT-4465A) 是一种基于免疫球蛋白 G1 且靶向 CD20 (B 细胞) 和 CD3 (T 细胞) 的人源化抗体。Mosunetuzumab 重定向 T 细胞以接合和消除恶性 B 细胞，可用于研究复发或难治性 (R R) B 细胞非霍奇金淋巴瘤 (B-NHL)和难治性滤泡性淋巴瘤。

Brigimadlin (BI 907828) 是一种具有口服活性和高效性的 E3 泛素蛋白连接酶 MDM2-p53 拮抗剂，具有抗肿瘤活性。Brigimadlin 可用于研究转移性BTC、PDAC、肺腺癌或膀胱癌。